Endodiag is specialized in the development of products and services aimed at improving the diagnosis of endometriosis. With its EndoGram prognosis program, the Company contributes to improving current diagnostic practice by providing additional biological information for a personalized medical and therapeutic management for each patient. In parallel, Endodiag develops a new non-invasive diagnostic test making endometriosis detection much easier and faster. Finally, the Company offers drug testing services to pharmaceutical companies enabling them to make early in-vitro evaluation of drug efficacy of cell lines and patient-derived cell cultures.
|Employees (est.) (Feb 2019)||17|
Endodiag total Funding
Endodiag latest funding size
Time since last funding
|4 years ago|
|Compound, Zelkova Ventures, Harmonic, Pat Condon|
Endodiag has 217 Twitter Followers. The number of followers has increased 1.3% month over month and increased 2.1% quarter over quarter
When was Endodiag founded?
Endodiag was founded in 2011.
How many employees does Endodiag have?
Endodiag has 17 employees.
Who are Endodiag competitors?
Competitors of Endodiag include Future Family, Geratherm and Prelude Fertility.
Where is Endodiag headquarters?
Endodiag headquarters is located at 4 Rue Pierre Fontaine, Évry.
Where are Endodiag offices?
Endodiag has an office in Évry.
How many offices does Endodiag have?
Endodiag has 1 office.